Zimmer Biomet Holdings, Inc.
ZBH Healthcare Medical Devices
Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024. In the quarter to June 2026, revenue grew 4.80%, EPS grew 33.8%, free cash flow grew 13.1% and total debt fell 1.23%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five.
Follow ZBH
Zimmer Biomet Holdings, Inc. (ZBH) Return on invested capital
Zimmer Biomet Holdings, Inc.'s return on invested capital over the twelve months to 30 June 2026 was 3.82%, up 0.3 percentage points from fiscal 2025 (3.50%). Over the past ten years it has ranged from 0.11% (fiscal 2018) to 4.48% (fiscal 2023); the current reading is higher than 73% of that period. That is above the Medical Devices industry median of −10.3% and above the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | 3.50% | (0.93) |
| FY2024 | 4.43% | (0.05) |
| FY2023 | 4.48% | 1.97 |
| FY2022 | 2.51% | (0.27) |
| FY2021 | 2.78% | 2.51 |
| FY2020 | 0.27% | (3.29) |
| FY2019 | 3.56% | 3.45 |
| FY2018 | 0.11% | (2.23) |
| FY2017 | 2.34% | (0.19) |
| FY2016 | 2.53% | 1.05 |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| DXCM DexCom, Inc. compare | 37.1% |
| PEN Penumbra, Inc. compare | 13.1% |
| GMED Globus Medical, Inc. compare | 9.58% |
| GEHC GE HealthCare Technologies Inc. compare | 8.37% |
| STE STERIS plc compare | 8.27% |
| PHG Koninklijke Philips N.V. compare | 6.69% |
| ZBH Zimmer Biomet Holdings, Inc. | 3.82% |
| BIO.B Bio-Rad Laboratories, Inc. compare | 0.49% |
| SNN Smith & Nephew SNATS, Inc. compare | 0.00% |
| Medical Devices industry median | −10.3% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on ZBH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement